EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,009,960 | +1.8% | 99,996 | 0.0% | 0.05% | -18.6% |
| Q3 2022 | $992,000 | +1.4% | 99,996 | 0.0% | 0.06% | +28.3% |
| Q2 2022 | $978,000 | +0.2% | 99,996 | 0.0% | 0.05% | +17.9% |
| Q1 2022 | $976,000 | +0.6% | 99,996 | 0.0% | 0.04% | +11.4% |
| Q4 2021 | $970,000 | -0.1% | 99,996 | 0.0% | 0.04% | +12.9% |
| Q3 2021 | $971,000 | +0.5% | 99,996 | 0.0% | 0.03% | +34.8% |
| Q2 2021 | $966,000 | – | 99,996 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |